A neurodegenerative cellular stress response linked to dark microglia and toxic lipid secretion
- PMID: 39719704
- DOI: 10.1016/j.neuron.2024.11.018
A neurodegenerative cellular stress response linked to dark microglia and toxic lipid secretion
Abstract
The brain's primary immune cells, microglia, are a leading causal cell type in Alzheimer's disease (AD). Yet, the mechanisms by which microglia can drive neurodegeneration remain unresolved. Here, we discover that a conserved stress signaling pathway, the integrated stress response (ISR), characterizes a microglia subset with neurodegenerative outcomes. Autonomous activation of ISR in microglia is sufficient to induce early features of the ultrastructurally distinct "dark microglia" linked to pathological synapse loss. In AD models, microglial ISR activation exacerbates neurodegenerative pathologies and synapse loss while its inhibition ameliorates them. Mechanistically, we present evidence that ISR activation promotes the secretion of toxic lipids by microglia, impairing neuron homeostasis and survival in vitro. Accordingly, pharmacological inhibition of ISR or lipid synthesis mitigates synapse loss in AD models. Our results demonstrate that microglial ISR activation represents a neurodegenerative phenotype, which may be sustained, at least in part, by the secretion of toxic lipids.
Keywords: Alzheimer’s disease; ISR; dark microglia; integrated stress response; lipid secretion; lipotoxicity; microglia; neurodegeneration; neurotoxic microglia; non-cell-autonomous stress.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Clec7a Signaling in Microglia Promotes Synapse Loss Associated with Tauopathy.Int J Mol Sci. 2025 Mar 22;26(7):2888. doi: 10.3390/ijms26072888. Int J Mol Sci. 2025. PMID: 40243488 Free PMC article.
-
Microbial pathogens induce neurodegeneration in Alzheimer's disease mice: protection by microglial regulation.J Neuroinflammation. 2022 Jan 6;19(1):5. doi: 10.1186/s12974-021-02369-8. J Neuroinflammation. 2022. PMID: 34991645 Free PMC article.
-
Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer's pathology in 5×FAD mice.Neurobiol Dis. 2021 May;152:105272. doi: 10.1016/j.nbd.2021.105272. Epub 2021 Feb 1. Neurobiol Dis. 2021. PMID: 33540048 Free PMC article.
-
Microglia in Alzheimer's disease.J Cell Biol. 2018 Feb 5;217(2):459-472. doi: 10.1083/jcb.201709069. Epub 2017 Dec 1. J Cell Biol. 2018. PMID: 29196460 Free PMC article. Review.
-
Targeting Microglia-Synapse Interactions in Alzheimer's Disease.Int J Mol Sci. 2021 Feb 26;22(5):2342. doi: 10.3390/ijms22052342. Int J Mol Sci. 2021. PMID: 33652870 Free PMC article. Review.
Cited by
-
Integrating genetic and immune profiles for personalized immunotherapy in Alzheimer's disease.Front Med (Lausanne). 2025 Jun 2;12:1603553. doi: 10.3389/fmed.2025.1603553. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40529145 Free PMC article. Review.
-
Regulation of synaptic function and lipid metabolism.Neural Regen Res. 2026 Mar 1;21(3):1037-1057. doi: 10.4103/NRR.NRR-D-24-01412. Epub 2025 Apr 29. Neural Regen Res. 2026. PMID: 40313084 Free PMC article.
-
Controlling CRISPR-Cas9 genome editing in human cells using a molecular glue degrader.Mol Ther Nucleic Acids. 2025 Jul 21;36(3):102640. doi: 10.1016/j.omtn.2025.102640. eCollection 2025 Sep 9. Mol Ther Nucleic Acids. 2025. PMID: 40799508 Free PMC article.
-
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research.Mol Neurodegener. 2025 Mar 27;20(1):37. doi: 10.1186/s13024-025-00825-0. Mol Neurodegener. 2025. PMID: 40149001 Free PMC article. Review.
-
RNA triggers chronic stress during neuronal aging.bioRxiv [Preprint]. 2025 Aug 5:2025.08.04.668575. doi: 10.1101/2025.08.04.668575. bioRxiv. 2025. PMID: 40799579 Free PMC article. Preprint.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases